Denali Therapeutics (DNLI)
(Delayed Data from NSDQ)
$16.60 USD
-0.22 (-1.31%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $16.58 -0.02 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.67 | -13.01% |
Earnings Summary
For their last quarter, Denali Therapeutics (DNLI) reported earnings of -$0.86 per share, missing the Zacks Consensus Estimate of -$0.82 per share. This reflects a negative earnings surprise of 4.88%. Look out for DNLI's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.67 per share, reflecting a year-over-year increase of 16.25%.
Earnings History
Price & Consensus
Zacks News for DNLI
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
DNLI: What are Zacks experts saying now?
Zacks Private Portfolio Services